MedPath

The effect of isotretinoin in the treatment of acne

Not Applicable
Conditions
Acne.
Acne Vulgaris
Registration Number
IRCT2017052725407N2
Lead Sponsor
Jahrom University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
36
Inclusion Criteria

18-30 years old women with moderate to severe acne vulgaris.
Exclusion criteria: pregnancy; hypersensitivity to parabens; poly cystic ovarian disease; recent history of mood or depressive disorders; thyroid disease; pituitary disease and use of Finasteride; retinoids or hormonal contraception within three months of enrollment.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Dihydrotestosterone. Timepoint: Before and after the intervention. Method of measurement: ng/ml.;17-hydroxyprogestrone. Timepoint: Before and after the intervention. Method of measurement: ng/ml.;Testosterone. Timepoint: Before and after the intervention. Method of measurement: ng/ml.;Dehydroepiandrosterone. Timepoint: Before and after the intervention. Method of measurement: ng/ml.;Free testosterone. Timepoint: Before and after the intervention. Method of measurement: ng/ml.;Luteinizing hormone. Timepoint: Before and after the intervention. Method of measurement: ng/ml.;Follicle stimulating hormone. Timepoint: Before and after the intervention. Method of measurement: ng/ml.;Prolactin. Timepoint: Before and after the intervention. Method of measurement: ng/ml.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath